0000914190-13-000737.txt : 20131024
0000914190-13-000737.hdr.sgml : 20131024
20131024165217
ACCESSION NUMBER: 0000914190-13-000737
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131022
FILED AS OF DATE: 20131024
DATE AS OF CHANGE: 20131024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiovascular Systems Inc
CENTRAL INDEX KEY: 0001180145
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411698056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 651 CAMPUS DRIVE
CITY: ST. PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 651-259-1600
MAIL ADDRESS:
STREET 1: 651 CAMPUS DRIVE
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: REPLIDYNE INC
DATE OF NAME CHANGE: 20020813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Martin David
CENTRAL INDEX KEY: 0001304318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52082
FILM NUMBER: 131168625
MAIL ADDRESS:
STREET 1: 651 CAMPUS DRIVE
CITY: ST. PAUL
STATE: MN
ZIP: 55112
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-10-22
0001180145
Cardiovascular Systems Inc
CSII
0001304318
Martin David
651 CAMPUS DRIVE
ST. PAUL
MN
55112
1
1
0
0
President and CEO
Common Stock
2013-10-22
4
M
0
50000
8.83
A
404052
D
Common Stock
2013-10-22
4
M
0
24717
8.83
A
428769
D
Common Stock
2013-10-22
4
S
0
37575
26.271
D
391194
D
Common Stock
2013-10-22
4
S
0
37142
27.09
D
354052
D
Common Stock
2013-10-23
4
M
0
29363
8.83
A
383415
D
Common Stock
2013-10-23
4
S
0
20277
27.29
D
363138
D
Common Stock
2013-10-23
4
S
0
9086
28.15
D
354052
D
Common Stock
2013-10-23
4
M
0
50000
8.83
A
404052
D
Common Stock
2013-10-23
4
S
0
50000
29.3947
D
354052
D
Common Stock
1400
I
By child
Common Stock
1400
I
By child
Common Stock
1400
I
By child
Stock Option (right to buy)
8.83
2013-10-22
4
M
0
50000
0
D
2016-07-16
Common Stock
50000
0
D
Stock Option (right to buy)
8.83
2013-10-22
4
M
0
24717
0
D
2017-02-14
Common Stock
24717
279363
D
Stock Option (right to buy)
8.83
2013-10-23
4
M
0
29363
0
D
2017-02-14
Common Stock
29363
250000
D
Stock Option (right to buy)
8.83
2013-10-23
4
M
0
50000
0
D
2017-02-14
Common Stock
50000
200000
D
Stock Option (right to buy)
7.90
2017-06-11
Common Stock
90580
90580
D
Stock Option (right to buy)
12.15
2017-12-11
Common Stock
234395
234395
D
Stock Option (right to buy)
8.75
2019-03-01
Common Stock
32350
32350
D
The shares were sold pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.85 to $26.82 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.85 to $27.83 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.99 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.01 to $28.43 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.98 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Fully exercisable.
/s/ Alexander Rosenstein as Attorney-in-Fact for David L. Martin pursuant to Power of Attorney previously filed.
2013-10-24